Monographie - Ketorolac tromethamine

Laatste update :
08/05/2024

Ketorolac tromethamine

Molecuulstructuur

Merknamen in verschillende landen

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Bedoral	Zuid-Afrika
Ketorolac trometamol	Groot Britannië
Lixidol	Italië
Taradyl	België
Toradol	Denemarken, Finland, Groot Britannië, Italië, Noorwegen, Spanje, Zweden

Literatuur : Ketorolac tromethamine

	Type	Publicatie
59	Artikel	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
216	Artikel	Huang E, Anderson RP. Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine. Am J Hosp Pharm 1994 ; 51: 2963.
228	Artikel	Mendenhall A, Hoyt DB. Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate. Am J Hosp Pharm 1994 ; 51: 2964.
299	Artikel	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
451	Artikel	Das Gupta V, Maswoswe J, Bailey RE. Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections. Int J Pharm Compound 1997 ; 1: 206-207.
469	Artikel	Floy BJ, Royko CJ, Fleitman JS. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets. Am J Hosp Pharm 1990 ; 47: 1097-1100.
476	Artikel	Knapp AJ, Mauro VF, Alexander KS. Incompatibility of ketorolac tromethamine with selected postoperative drugs. Am J Hosp Pharm 1992 ; 49: 2960-2962.
1634	Artikel	Shi A, Walker SE, Law S. Stability of ketorolac tromethamine in IV solutions and waste reduction. Can J Hosp Pharm 2000 ; 53: 263-269.
1712	Artikel	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1721	Artikel	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1800	Artikel	Voytilla KL, Tyler LS, Rusho WJ. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. Am J Health-Syst Pharm 2002 ; 59: 853-855.
1803	Artikel	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1859	Artikel	Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G. Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Il Farmaco 2002 ; 57: 925-930.
1974	Artikel	Chandler SW, Trissel LA, Weinstein SM Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility. J Pain Symptom Manage 1996 ; 12, 3: 168-171.
2015	Artikel	Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM. Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine. Ann Pharmacotherapy 2005 39: 1654-1658.
2124	Artikel	Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L. Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C. EJHP Science 2006 ; 12, 4: 72-75.
2166	Artikel	Nassr S, Dubuc MC, Lavoie P, Brazier JL. HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine. J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.
3159	Artikel	Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z. Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution. Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.
3169	Artikel	Raffaeli W, Pari G, Visani L et al. Experimentation about precipitation of pharmacological association: morphine and ketorolac. Pain Clinic 1999 ; 11: 213-216.
3374	Artikel	Smith R.P.R, Jones M. Precipitation in Manchester: ketorolac/cyclizine Anaesthesia 2001 ; 56: 494-495.
3470	Artikel	Destro M, Ottolini L, Vicentini L, Boschetti S. Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care. Support Care Cancer 2012 ; 20: 2501-2509.
3571	Artikel	Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M. Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration. Hosp Pharm 2014 ; 49, 1: 42-47.
3593	Fabrikant	Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics Beacon Pharmaceuticals 2011
3601	Fabrikant	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
4433	Artikel	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4435	Artikel	Hanifah S, Nugroho B.H, Chabib L. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.

Mentions Légales